[Form 4] Claritev Corp Insider Trading Activity

Rhea-AI Filing Summary

Claritev Corp (CTEV) officer Albinson Brock reported a non‑derivative acquisition of 2,825 Class A common shares on 09/30/2025 via a restricted stock unit grant recorded at $0. The filing shows these RSUs vest in equal annual installments of 25% on each September 30, 2026, 2027, 2028 and 2029. Following the reported transaction, Mr. Brock is shown as beneficially owning 2,825 shares. The Form 4 was executed by an attorney‑in‑fact signature dated 10/01/2025 and identifies the reporting person as SVP, Chief Accounting Officer.

Insights

Financial Analyst

TL;DR: Officer received a small RSU grant vesting over four years; impact on share count and cash flow is minimal.

The 2,825 RSU grant to the SVP/Chief Accounting Officer is disclosed as an acquisition at $0, indicating restricted stock units rather than cash purchase. Vesting occurs in four equal annual tranches beginning one year after grant. The size of the grant relative to typical public company equity pools appears small based on absolute share count; there is no information here about outstanding shares or plan limits, so materiality to EPS or ownership percentages cannot be determined from this filing alone.

Corporate Governance Expert

TL;DR: Routine executive compensation disclosure; standard multi‑year vesting schedule aligns with retention practices.

The Form 4 documents a standard equity compensation mechanism for an officer with graded vesting over multiple years. The filing is properly signed by an attorney‑in‑fact and identifies the reporting person and relationship. The document does not disclose grant authorization details, equity plan reference, or relative grant size versus total dilution, limiting governance conclusions to the vesting schedule and acquisition mechanics recorded.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Albinson Brock

(Last) (First) (Middle)

C/O CLARITEV CORPORATION

7900 TYSONS ONE PLACE, SUITE 400

(Street)

MCLEAN VA 22102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, par value $0.0001 per share	09/30/2025		A(1)		2,825	A	$0	2,825	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units which shall vest at a rate of 25% per year on each of September 30, 2026, 2027, 2028, and 2029.

Remarks:

	/s/ Kent Bartholomew, attorney-in-fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Claritev Corp (CTEV) disclose in this Form 4?

The filing reports an acquisition of 2,825 Class A common shares by SVP/Chief Accounting Officer Albinson Brock on 09/30/2025 as restricted stock units recorded at $0.

How do the restricted stock units vest for the reported grant?

The RSUs vest at a rate of 25% per year on each of September 30, 2026, 2027, 2028, and 2029.

How many shares does the reporting person own after the transaction?

The Form 4 shows 2,825 shares beneficially owned following the reported transaction.

Was there a cash purchase price for the shares reported?

No; the transaction price is listed as $0, consistent with an RSU grant rather than a cash purchase.

Who signed the Form 4 and when?

The filing was signed by an attorney‑in‑fact, /s/ Kent Bartholomew, with a signature date of 10/01/2025.